Halozyme prices $1.3B convertible notes due 2033
Halozyme priced $1.3 billion of 1.50% convertible senior notes due 2033 and granted a 13-day option to sell up to $200 million more.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Halozyme prices upsized $1.3B 1.50% converts due 2033
Halozyme priced $1.3B of 1.50% convertible senior notes due 2033, upsized from $1.05B. The initial conversion price was $139.84, with capped calls to $208.39. Net proceeds were about $1.275B.